How Health Systems Can Reduce Financial Risk Through Smarter Logistics

Logistics in Crisis

U.S. health systems are grappling with escalating financial strains in 2026, driven by a confluence of policy shifts and economic pressures. Tariffs imposed on imported medical supplies and pharmaceuticals have raised costs significantly, with average effective rates reaching 18 percent—the highest since 1934. These measures, aimed at bolstering domestic production, have instead compounded existing inflationary trends in raw materials and components. Simultaneously, anticipated reductions in Medicaid funding and potential lapses in Affordable Care Act subsidies threaten to increase the uninsured population, placing additional burden on providers already contending with reimbursement gaps.

Workforce shortages and rising labor costs further erode margins, with earnings before interest, taxes, depreciation, and amortization projected to dip into negative territory for many systems through 2026. Supply chain disruptions, including those from geopolitical tensions and cyber attacks, have evolved from isolated incidents to systemic risks. For instance, cyber incidents targeting logistics providers surged 61 percent in 2025, leading to delays in critical deliveries and heightened operational vulnerabilities. Health systems report that these interruptions not only inflate costs but also compromise patient outcomes through treatment delays and repeat testing.

The real-world impact is stark: smaller and rural hospitals face heightened closure risks, potentially leaving millions without local access to care. In 2025, financial instability led to pauses in mergers and acquisitions, but a rebound is expected in 2026 as organizations seek scale to weather the storm. Patients bear the brunt through higher out-of-pocket expenses, with individual expenditures forecasted to rise 3.7 percent annually. Providers, meanwhile, are outsourcing logistics and supply chain functions to cut costs, though this introduces new dependencies and potential points of failure.

Concrete stakes include deadlines like the May 31, 2026, reporting requirement under the Supply Chains Act, which mandates transparency on modern slavery risks in procurement—a compliance burden amid already strained resources. Costs are mounting: medical supply inflation is pegged at 2.58 percent for 2026, while pharmacy prices could climb 2.84 percent starting mid-year. Inaction carries severe consequences, such as stockouts of essential drugs—over 250 medications were in shortage nationwide in late 2025—or disrupted revenue cycles from cyber breaches, which doubled in the sector that year.

Non-obvious angles reveal tensions between stakeholders. Diversifying supply sources to reduce reliance on single countries like China enhances resilience but elevates immediate expenses, creating a trade-off with demands for rapid returns on AI investments in supply management. Cybersecurity scrutiny in vendor contracts is a pain point for 68 percent of leaders, as digital interdependencies turn cyber threats into supply chain crises. Surprising data shows that while inpatient revenues grew 9.8 percent year-over-year through September 2025, the shift to outpatient care—up 12.8 percent—signals a reconfiguration of delivery models, yet persistent clinician burnout undermines these efficiencies.